Anorectic Drugs and Pulmonary Hypertension from the Bedside to the Bench
- 1 April 2001
- journal article
- review article
- Published by Elsevier BV in The American Journal of the Medical Sciences
- Vol. 321 (4), 292-299
- https://doi.org/10.1097/00000441-200104000-00009
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Activity of voltage-gated K+ channels is associated with cell proliferaton and Ca2+ influx in carcinoma cells of colon cancerLife Sciences, 1999
- The Long QT Syndrome: Ion Channel Diseases of the HeartMayo Clinic Proceedings, 1998
- SibutramineDrugs, 1998
- Further Cases of Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Fatal Pulmonary Hypertension Associated with Short-Term Use of Fenfluramine and PhentermineNew England Journal of Medicine, 1997
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Appetite-Suppressant Drugs and the Risk of Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Remission of high blood pressure reverses arterial potassium channel alterations.Hypertension, 1994
- DexfenfluramineDrugs, 1992
- Myocardial infarction associated with the use of dextrofenfluramine.BMJ, 1990